-
公开(公告)号:EP1090009A2
公开(公告)日:2001-04-11
申请号:EP99926157.1
申请日:1999-06-03
Applicant: ABBOTT LABORATORIES
Inventor: STEWART, Andrew, O. , BOYD, Steven, A. , ARENDSEN, David, L. , BHATIA, Pramila , CONDROSKI, Kevin, R. , FREEMAN, Jennifer, C. , GUNAWARDANA, Indrani, W. , ZHU, Gui-Dong , LARTEY, Kraig , MCCARTY, Catherine, M. , MORT, Nicholas, A. , PATEL, Meena V. , STAEGER, Michael, A. , STOUT, David, M.
IPC: C07D495/04 , C07D498/04 , C07D513/04 , C07D471/04 , C07D491/04 , A61K31/44 , A61K31/50 , A61K31/505
CPC classification number: C07D471/04 , C07D491/04 , C07D495/04 , C07D513/04
Abstract: Compounds having Formula (I) are useful for treating inflammation. Also disclosed are pharmaceutical compositions comprising compouns of Formula (I), and methods of inhibiting/treating inflammatory diseases in a mammal.
Abstract translation: 具有式(I)的化合物可用于治疗炎症。 还公开了包含式(I)化合物的药物组合物,以及在哺乳动物中抑制/治疗炎性疾病的方法。
-
12.CYCLOBUTANE DERIVATIVES AS INHIBITORS OF SQUALENE SYNTHETASE AND PROTEIN FARNESYLTRANSFERASE 失效
Title translation: CYCLOBUTAN-DERIVATE ALS INHIBITOREN DER SQUALEN-SYNTHETASE UND DER PROTEIN-FARNESYLTRANSFERASE。公开(公告)号:EP0677039A1
公开(公告)日:1995-10-18
申请号:EP94931987.0
申请日:1994-10-20
Applicant: Abbott Laboratories
Inventor: BAKER, William, R. , ROCKWAY, Todd, W. , DONNER, B., Gregory , SHEN, Wang , ROSENBERG, Saul, H. , FAKHOURY, Stephen, A. , O'CONNOR, Stephen, J. , STOUT, David, M. , FUNG, Anthony, K., L. , GARVEY, David, S. , PRASAD, Rajnandan , SULLIVAN, Gerard, M.
IPC: C12N9 , A61K31 , A61P3 , A61P7 , A61P9 , A61P31 , A61P43 , C07C69 , C07C231 , C07C233 , C07C235 , C07C237 , C07C245 , C07C251 , C07C259 , C07C275 , C07C311 , C07C323 , C07C327 , C07D207 , C07D213 , C07D257 , C07D263 , C07D271 , C07D277 , C07D285 , C07D307 , C07D309 , C07D317 , C07D319 , C07D333
CPC classification number: C07C233/61 , C07C69/74 , C07C233/19 , C07C233/58 , C07C233/59 , C07C233/60 , C07C233/62 , C07C233/63 , C07C235/36 , C07C235/40 , C07C237/24 , C07C245/14 , C07C251/42 , C07C259/08 , C07C311/51 , C07C323/40 , C07C323/46 , C07C2601/02 , C07C2601/04 , C07C2601/14 , C07D309/32 , C07D319/06 , C07D333/58
Abstract: The present invention provides a compound of formula (I) processes for the preparation of the compounds of the invention in addition to intermediates useful in these processes, a pharmaceutical composition, and a method of treating disorders resulting from an excess of cholesterol or cancer or a fungal infection.
Abstract translation: 本发明提供式(I)化合物,除了可用于这些方法的中间体以外,还可用于制备本发明化合物的方法,药物组合物和治疗由过量胆固醇或癌症引起的病症的方法或 真菌感染。
-